{
  "legislationId": "119_HR_7879",
  "lastUpdate": "2026-04-02T11:19:08.544Z",
  "history": [
    {
      "timestamp": "2026-04-02T11:19:08.544Z",
      "source_url": "https://www.congress.gov/119/bills/hr7879/BILLS-119hr7879ih.htm",
      "model": "gemini-flash-lite-latest",
      "prompt_sent": "\nROLE: Fact Checker.\nZADANIE: Porównaj SOURCE (oryginał) i SUMMARY (streszczenie przygotowane przez inne AI).\n\nTwoim celem jest wykrycie \"ZMYŚLONYCH KONKRETÓW\" (Fabricated Entities) w SUMMARY.\n\nSOURCE:\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7879 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7879 To require the Secretary of State, in consultation with the Secretary of Health and Human Services and other relevant departments and agencies, as appropriate, to formulate a strategy for the Federal Government to secure support from foreign countries, multilateral organizations, and other appropriate entities to facilitate the development and commercialization of qualified pandemic or epidemic products, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 9, 2026 Mr. Levin (for himself and Mr. Valadao) introduced the following bill; which was referred to the Committee on Foreign Affairs _______________________________________________________________________ A BILL To require the Secretary of State, in consultation with the Secretary of Health and Human Services and other relevant departments and agencies, as appropriate, to formulate a strategy for the Federal Government to secure support from foreign countries, multilateral organizations, and other appropriate entities to facilitate the development and commercialization of qualified pandemic or epidemic products, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLES. This Act may be cited as the ``Saving Us from Pandemic Era Resistance by Building a Unified Global Strategy Act of 2026'' or the ``SUPER BUGS Act of 2026''. SEC. 2. FINDINGS. Congress finds the following: (1) Emerging infectious diseases, including antimicrobial- resistant pathogens, pose a significant threat to United States national security by-- (A) increasing the risk of outbreaks reaching the United States; (B) disrupting critical infrastructure; (C) undermining economic stability and public health; and (D) undermining the readiness of the United States Armed Forces abroad. (2) Strengthening international collaboration to develop, commercialize, and deploy qualified pandemic and epidemic products is essential to preventing, detecting, and containing infectious disease threats before they reach the borders of the United States. (3) Enhancing partner countries' public health capabilities and pandemic and epidemic response mechanisms directly contributes to United States homeland security by reducing the likelihood of global outbreaks affecting the United States. (4) Coordinated strategies that leverage United States leadership, technology, and medical countermeasures, while ensuring equitable access for international partners, promote global resilience and reduce threats to United States citizens, infrastructure, and national interests. SEC. 3. DEFINITIONS. In this Act: (1) Appropriate committees of congress.--The term ``appropriate committees of Congress'' means-- (A) the Committee on Foreign Relations of the Senate; (B) the Committee on Health, Education, Labor, and Pensions of the Senate; (C) the Committee on Foreign Affairs of the House of Representatives; and (D) the Committee on Energy and Commerce of the House of Representatives. (2) Priority pathogens.--The term ``priority pathogens'' means pathogens identified in-- (A) the latest ``Antibiotic Resistance Threats Report'' of the Centers for Disease Control and Prevention (or any successor report); or (B) the current list of qualifying pathogens maintained by the Secretary of Health and Human Services under section 505E(f)(2) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355f(f)(2)) (or any successor list). (3) Qualified pandemic or epidemic product.--The term ``qualified pandemic or epidemic product'' has the meaning given such term in section 319F-3(i) of the Public Health Service Act (42 U.S.C. 247d-6d(i)). SEC. 4. INTERNATIONAL STRATEGY FOR DEVELOPMENT OF QUALIFIED PANDEMIC OR EPIDEMIC PRODUCTS. (a) Strategy.-- (1) In general.--Not later than 18 months after the date of the enactment of this Act, the Secretary of State, in consultation with the Secretary of Health and Human Services, and such other heads of departments and agencies as the Secretary of State considers appropriate, shall-- (A) formulate a strategy for the Federal Government to secure support from foreign countries, multilateral organizations, and other appropriate entities to facilitate the development and commercialization of qualified pandemic or epidemic products, including products to address antimicrobial resistant pathogens-- (i) with pandemic potential; or (ii) that are priority pathogens; and (B) submit such strategy to the appropriate committees of Congress. (2) Contents.--The strategy required under paragraph (1) shall-- (A) provide for processes the Federal Government is using and would use to enter into arrangements with foreign countries, multilateral organizations, and other appropriate entities in certain circumstances to implement the strategy; (B) strive to ensure that the arrangements described in subparagraph (A) promote equitable contributions based on the budgets and technical expertise of participating countries, organizations, and other entities, as appropriate; (C) focus the arrangements described in subparagraph (A) on global priorities, while enabling participating countries, organizations, and other entities to emphasize national or regional issues of importance; (D) support efforts to strengthen partner country public health capabilities by promoting sustainable improvements in their ability to prevent, detect, and contain infectious disease threats; (E) seek to ensure that new and existing arrangements described in subparagraph (A) are harmonized with each other and with other relevant existing or planned efforts to amplify impact, address gaps, prevent duplication of effort, and efficiently distribute funds; (F) provide for collaboration to ensure the arrangements described in subparagraph (A) allocate joint or individual responsibility across participating countries, organizations, and other entities for the development and commercialization of particular qualified pandemic or epidemic products, where such collaboration is clearly described in such arrangement; (G) provide for the stewardship of qualified pandemic or epidemic products developed pursuant to the strategy; (H) identify priority actions in the arrangements described in subparagraph (A) so that scarce domestic and international funds are allocated to develop and commercialize qualified pandemic or epidemic products that can achieve the greatest positive impact on human health, including unprecedented approaches to preventing, treating, and diagnosing infectious diseases; (I) consider securing contracts with United States companies and the broader private sector, entering into public-private partnerships, implementing alternative payment models, creating coverage and reimbursement pathways, and streamlining regulatory approval processes; and (J) be synchronized with United States pandemic preparedness priorities, such as those articulated in-- (i) the National Strategy for Combating Antibiotic-Resistant Bacteria (dated September 2014); and (ii) the National Biodefense Strategy and Implementation Plan (dated October 2022) and the associated Action Plan (dated October 2022). (b) Arrangements With Foreign Countries and Multilateral Organizations.--The Secretary of State, in consultation with the Secretary of Health and Human Services, and the heads of other relevant departments and agencies, as appropriate, shall seek to enter into arrangements with foreign countries, multilateral organizations, and other appropriate entities to implement the strategy required under subsection (a). <all>\n\nSUMMARY TO EVALUATE:\nTitle: SUPER BUGS Act of 2026: A Global Strategy for Pandemic Preparedness\nSummary: This bill requires the U.S. government to create a global plan to develop and bring to market medical products for future pandemics. By working with international partners, the goal is to stop infectious diseases and drug-resistant bacteria before they reach the United States.\nKey Points: Creation of a strategy to secure international support for new vaccines and treatments., Focus on 'superbugs' and pathogens that could cause global health crises., Strengthening the ability of other countries to detect and contain outbreaks early., Partnering with private companies to speed up the development of medical countermeasures.\n\nZASADY OCENY:\n1. Sprawdź wszystkie LICZBY, DATY i KWOTY w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n2. Sprawdź wszystkie NAZWISKA, ORGANIZACJE i MIEJSCA w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n3. Sprawdź wszystkie konkretne DZIAŁANIA PRAWNE . Jeśli tego mechanizmu nie ma w SOURCE -> is_valid: false.\n\nWAŻNE: Abstrakcyjne pojęcia (np. \"transparentność\", \"zaufanie\") są dozwolone jako wnioski.\n\nOUTPUT (JSON):\n{\n  \"is_valid\": true/false,\n  \"issue\": \"fabricated_entity\" / \"contradiction\" / \"none\"\n}\n\nWYMAGANIA FORMATOWANIA:\n1. Odpowiedz WYŁĄCZNIE surowym obiektem JSON.\n2. NIE używaj bloków kodu Markdown.\n3. NIE dodawaj żadnych wstępów ani wyjaśnień przed ani po JSONie.\n4. JSON musi być poprawny i gotowy do parsowania.\n\n",
      "ai_response_raw": "{\n  \"is_valid\": true,\n  \"issue\": \"none\"\n}"
    },
    {
      "timestamp": "2026-04-02T11:12:33.363Z",
      "source_url": "https://www.congress.gov/119/bills/hr7879/BILLS-119hr7879ih.htm",
      "model": "gemini-flash-latest",
      "prompt_sent": "\nJesteś ekspertem od prawa Stanów Zjednoczonych, który ma za zadanie analizować dokumenty ustaw, uchwał oraz innych dokumentów legislacyjnych, a następnie przygotowywać z nich informacje w przystępny sposób dla obywateli. Twoim celem jest przedstawienie informacji tak, aby obywatele mogli sami ocenić wpływ legislacji na ich życie, nawet bez posiadania specjalistycznej wiedzy legislacyjnej. Skup się na faktach i obiektywnych skutkach wprowadzanych zmian, unikając wartościowania i osobistych opinii. Wszelki żargon prawny jest zabroniony. Prezentuj informacje w jasny, zwięzły i angażujący sposób, tak aby były zrozumiałe dla osoby bez wykształcenia prawniczego. Unikaj długich, złożonych zdań. Zamiast pisać \"projekt ma na celu nowelizację kodeksu podatkowego...\", napisz \"Zmiany w podatkach: nowe ulgi i obowiązki dla...\". Kontynuuj swoją pracę, dopóki nie rozwiążesz swojego zadania. Jeśli nie masz pewności co do generowanej treści, przeanalizuj dokument ponownie – nie zgaduj. Rozplanuj dobrze swoje zadanie przed przystąpieniem do niego. W podsumowaniu i kluczowych punktach, jeśli to możliwe i uzasadnione, podkreśl, jakie konkretne korzyści lub skutki (pozytywne lub negatywne) wprowadza ustawa dla życia codziennego obywateli, ich praw i obowiązków, finansów osobistych, bezpieczeństwa i innych ważnych kwestii (np. kategorycznych zakazów i nakazów czy najważniejszych konkretnych alokacji finansowych i terytorialnych).\n\nTwoja odpowiedź MUSI być w formacie JSON - i zawierać następujące klucze.\nZanim zwrócisz odpowiedź, dokładnie zweryfikuj, czy cała struktura JSON jest w 100% poprawna, włącznie ze wszystkimi przecinkami, nawiasami klamrowymi, kwadratowymi oraz cudzysłowami. Błędny JSON jest nieakceptowalny i uniemożliwi przetworzenie Twojej pracy.\n\nPrzeanalizuj dokładnie poniższy tekst dokumentu prawnego. To jest treść, na podstawie której masz wygenerować podsumowanie i kluczowe punkty:\n--- POCZĄTEK DOKUMENTU ---\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7879 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7879 To require the Secretary of State, in consultation with the Secretary of Health and Human Services and other relevant departments and agencies, as appropriate, to formulate a strategy for the Federal Government to secure support from foreign countries, multilateral organizations, and other appropriate entities to facilitate the development and commercialization of qualified pandemic or epidemic products, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 9, 2026 Mr. Levin (for himself and Mr. Valadao) introduced the following bill; which was referred to the Committee on Foreign Affairs _______________________________________________________________________ A BILL To require the Secretary of State, in consultation with the Secretary of Health and Human Services and other relevant departments and agencies, as appropriate, to formulate a strategy for the Federal Government to secure support from foreign countries, multilateral organizations, and other appropriate entities to facilitate the development and commercialization of qualified pandemic or epidemic products, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLES. This Act may be cited as the ``Saving Us from Pandemic Era Resistance by Building a Unified Global Strategy Act of 2026'' or the ``SUPER BUGS Act of 2026''. SEC. 2. FINDINGS. Congress finds the following: (1) Emerging infectious diseases, including antimicrobial- resistant pathogens, pose a significant threat to United States national security by-- (A) increasing the risk of outbreaks reaching the United States; (B) disrupting critical infrastructure; (C) undermining economic stability and public health; and (D) undermining the readiness of the United States Armed Forces abroad. (2) Strengthening international collaboration to develop, commercialize, and deploy qualified pandemic and epidemic products is essential to preventing, detecting, and containing infectious disease threats before they reach the borders of the United States. (3) Enhancing partner countries' public health capabilities and pandemic and epidemic response mechanisms directly contributes to United States homeland security by reducing the likelihood of global outbreaks affecting the United States. (4) Coordinated strategies that leverage United States leadership, technology, and medical countermeasures, while ensuring equitable access for international partners, promote global resilience and reduce threats to United States citizens, infrastructure, and national interests. SEC. 3. DEFINITIONS. In this Act: (1) Appropriate committees of congress.--The term ``appropriate committees of Congress'' means-- (A) the Committee on Foreign Relations of the Senate; (B) the Committee on Health, Education, Labor, and Pensions of the Senate; (C) the Committee on Foreign Affairs of the House of Representatives; and (D) the Committee on Energy and Commerce of the House of Representatives. (2) Priority pathogens.--The term ``priority pathogens'' means pathogens identified in-- (A) the latest ``Antibiotic Resistance Threats Report'' of the Centers for Disease Control and Prevention (or any successor report); or (B) the current list of qualifying pathogens maintained by the Secretary of Health and Human Services under section 505E(f)(2) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355f(f)(2)) (or any successor list). (3) Qualified pandemic or epidemic product.--The term ``qualified pandemic or epidemic product'' has the meaning given such term in section 319F-3(i) of the Public Health Service Act (42 U.S.C. 247d-6d(i)). SEC. 4. INTERNATIONAL STRATEGY FOR DEVELOPMENT OF QUALIFIED PANDEMIC OR EPIDEMIC PRODUCTS. (a) Strategy.-- (1) In general.--Not later than 18 months after the date of the enactment of this Act, the Secretary of State, in consultation with the Secretary of Health and Human Services, and such other heads of departments and agencies as the Secretary of State considers appropriate, shall-- (A) formulate a strategy for the Federal Government to secure support from foreign countries, multilateral organizations, and other appropriate entities to facilitate the development and commercialization of qualified pandemic or epidemic products, including products to address antimicrobial resistant pathogens-- (i) with pandemic potential; or (ii) that are priority pathogens; and (B) submit such strategy to the appropriate committees of Congress. (2) Contents.--The strategy required under paragraph (1) shall-- (A) provide for processes the Federal Government is using and would use to enter into arrangements with foreign countries, multilateral organizations, and other appropriate entities in certain circumstances to implement the strategy; (B) strive to ensure that the arrangements described in subparagraph (A) promote equitable contributions based on the budgets and technical expertise of participating countries, organizations, and other entities, as appropriate; (C) focus the arrangements described in subparagraph (A) on global priorities, while enabling participating countries, organizations, and other entities to emphasize national or regional issues of importance; (D) support efforts to strengthen partner country public health capabilities by promoting sustainable improvements in their ability to prevent, detect, and contain infectious disease threats; (E) seek to ensure that new and existing arrangements described in subparagraph (A) are harmonized with each other and with other relevant existing or planned efforts to amplify impact, address gaps, prevent duplication of effort, and efficiently distribute funds; (F) provide for collaboration to ensure the arrangements described in subparagraph (A) allocate joint or individual responsibility across participating countries, organizations, and other entities for the development and commercialization of particular qualified pandemic or epidemic products, where such collaboration is clearly described in such arrangement; (G) provide for the stewardship of qualified pandemic or epidemic products developed pursuant to the strategy; (H) identify priority actions in the arrangements described in subparagraph (A) so that scarce domestic and international funds are allocated to develop and commercialize qualified pandemic or epidemic products that can achieve the greatest positive impact on human health, including unprecedented approaches to preventing, treating, and diagnosing infectious diseases; (I) consider securing contracts with United States companies and the broader private sector, entering into public-private partnerships, implementing alternative payment models, creating coverage and reimbursement pathways, and streamlining regulatory approval processes; and (J) be synchronized with United States pandemic preparedness priorities, such as those articulated in-- (i) the National Strategy for Combating Antibiotic-Resistant Bacteria (dated September 2014); and (ii) the National Biodefense Strategy and Implementation Plan (dated October 2022) and the associated Action Plan (dated October 2022). (b) Arrangements With Foreign Countries and Multilateral Organizations.--The Secretary of State, in consultation with the Secretary of Health and Human Services, and the heads of other relevant departments and agencies, as appropriate, shall seek to enter into arrangements with foreign countries, multilateral organizations, and other appropriate entities to implement the strategy required under subsection (a). <all>\n--- KONIEC DOKUMENTU ---\n\nPAMIĘTAJ: Twoja odpowiedź MUSI być wyłącznie poprawnym obiektem JSON. Nie dodawaj żadnych dodatkowych znaków, komentarzy ani tekstu przed znacznikiem '{' ani po znaczniku '}'. Cała odpowiedź musi być parsowalna jako JSON.\nNa podstawie POWYŻSZEGO dokumentu, wypełnij poniższą strukturę JSON:\nOto struktura JSON, której oczekuję (wypełnij ją treścią):\n{\n  \"pl_ai_title\": \"Nowy, krótki tytuł dla aktu prawnego po polsku, oddający sedno wprowadzanych zmian (np. maksymalnie 10-12 słów).\",\n  \"pl_summary\": \"2-3 zdania zwięzłego podsumowania treści aktu prawnego po polsku, napisane z perspektywy wpływu na życie codzienne obywateli.\",\n  \"pl_key_points\": [\n    \"Pierwszy krótki punkt po polsku dotyczący najważniejszych wprowadzanych rozwiązań lub zmian.\",\n    \"Drugi krótki punkt po polsku...\"\n  ],\n  \"eng_ai_title\": \"A new, short title for the legal act in English, capturing the essence of the changes (e.g., max 10-12 words).\",\n  \"eng_summary\": \"2-3 sentences summarizing the legal act in English, from the perspective of its impact on citizens' daily lives.\",\n  \"eng_key_points\": [\n    \"First short bullet point in English regarding the most important solutions or changes being introduced.\",\n    \"Second short bullet point in English...\"\n  ],\n  \"de_ai_title\": \"Ein neuer, kurzer Titel für das Rechtsdokument auf Deutsch, der den Kern der Änderungen erfasst (z.B. max. 10-12 Wörter).\",\n  \"de_summary\": \"2-3 Sätze Zusammenfassung des Rechtsdokuments auf Deutsch, aus der Perspektive seiner Auswirkungen auf das tägliche Leben der Bürger.\",\n  \"de_key_points\": [\n    \"Erster kurzer Stichpunkt auf Deutsch zu den wichtigsten eingeführten Lösungen oder Änderungen.\",\n    \"Zweiter kurzer Stichpunkt auf Deutsch...\"\n  ],\n  \"fr_ai_title\": \"Un nouveau titre court pour l'acte juridique en français, saisissant l'essence des changements (par exemple, 10-12 mots maximum).\",\n  \"fr_summary\": \"Résumé de 2-3 phrases de l'acte juridique en français, du point de vue de son impact sur la vie quotidienne des citoyens.\",\n  \"fr_key_points\": [\n    \"Premier court point en français concernant les solutions ou changements les plus importants introduits.\",\n    \"Deuxième court point en français...\"\n  ],\n  \"es_ai_title\": \"Un nuevo título breve para el acto jurídico en español, que recoja la esencia de los cambios (por ejemplo, máximo 10-12 palabras).\",\n  \"es_summary\": \"Resumen de 2-3 frases del acto jurídico en español, desde la perspectiva de su impacto en la vida cotidiana de los ciudadanos.\",\n  \"es_key_points\": [\n    \"Primer punto breve en español sobre las soluciones o cambios más importantes que se introducen.\",\n    \"Segundo punto breve en español...\"\n  ],\n  \"it_ai_title\": \"Un nuovo titolo breve per l'atto giuridico in italiano, che colga l'essenza delle modifiche (ad es. massimo 10-12 parole).\",\n  \"it_summary\": \"Riepilogo di 2-3 frasi dell'atto giuridico in italiano, dal punto di vista del suo impatto sulla vita quotidiana dei cittadini.\",\n  \"it_key_points\": [\n    \"Primo breve punto in italiano riguardante le soluzioni o le modifiche più importanti introdotte.\",\n    \"Secondo breve punto in italiano...\"\n  ],\n  \"nl_ai_title\": \"Een nieuwe, korte titel voor de rechtshandeling in het Nederlands, die de essentie van de wijzigingen weergeeft (bijv. max. 10-12 woorden).\",\n  \"nl_summary\": \"Samenvatting van 2-3 zinnen van de rechtshandeling in het Nederlands, vanuit het perspectief van de impact op het dagelijks leven van burgers.\",\n  \"nl_key_points\": [\n    \"Eerste korte punt in het Nederlands betreffende de belangrijkste geïntroduceerde oplossingen of wijzigingen.\",\n    \"Tweede korte punt in het Nederlands...\"\n  ],\n  \"pt_ai_title\": \"Um novo título curto para o ato jurídico em português, capturando a essência das mudanças (por exemplo, máx. 10-12 palavras).\",\n  \"pt_summary\": \"Resumo de 2-3 frases do ato jurídico em português, na perspetiva do seu impacto na vida quotidiana dos cidadãos.\",\n  \"pt_key_points\": [\n    \"Primeiro ponto curto em português sobre as soluções ou alterações mais importantes introduzidas.\",\n    \"Segundo ponto curto em português...\"\n  ],\n  \"category\": [\"Categorize the document into one category by default, based on the field it primarily concerns. Choose up to 3 if the document also touches upon SIGNIFICANT issues from other categories. You MUST select categories ONLY from the following list: Health, Education, Family, Taxes, Labor, Security, Environment, Courts and Law, Transport, Benefits, Real Estate, Media and Culture, Local Government, Migration, Agriculture, Public Investments, Informatization, Economy. If the document does not definitively fit any of these, you MUST use \"Other\". If you use \"Other\", it should be the ONLY category selected. Do NOT invent new categories. The response must be an array of strings, e.g., [\"Taxes\", \"Family\"].\"]\n}\n\n",
      "ai_response_raw": "{\n  \"pl_ai_title\": \"Ustawa SUPER BUGS 2026: Globalna strategia walki z pandemiami i odpornymi bakteriami\",\n  \"pl_summary\": \"Ustawa nakazuje opracowanie międzynarodowej strategii, która ma przyspieszyć tworzenie leków i szczepionek na wypadek przyszłych pandemii. Dzięki współpracy z innymi krajami, USA chcą powstrzymać groźne choroby, zanim dotrą one do granic kraju, co zwiększy bezpieczeństwo zdrowotne obywateli.\",\n  \"pl_key_points\": [\n    \"Opracowanie planu współpracy z innymi państwami w celu tworzenia nowych leków i testów diagnostycznych.\",\n    \"Skupienie się na zwalczaniu bakterii odpornych na antybiotyki, które stanowią zagrożenie dla bezpieczeństwa narodowego.\",\n    \"Wsparcie dla krajów partnerskich w celu szybszego wykrywania i powstrzymywania ognisk chorób zakaźnych.\",\n    \"Angażowanie firm prywatnych i sektora medycznego w rozwój nowoczesnych technologii chroniących zdrowie.\"\n  ],\n  \"eng_ai_title\": \"SUPER BUGS Act of 2026: A Global Strategy for Pandemic Preparedness\",\n  \"eng_summary\": \"This bill requires the U.S. government to create a global plan to develop and bring to market medical products for future pandemics. By working with international partners, the goal is to stop infectious diseases and drug-resistant bacteria before they reach the United States.\",\n  \"eng_key_points\": [\n    \"Creation of a strategy to secure international support for new vaccines and treatments.\",\n    \"Focus on 'superbugs' and pathogens that could cause global health crises.\",\n    \"Strengthening the ability of other countries to detect and contain outbreaks early.\",\n    \"Partnering with private companies to speed up the development of medical countermeasures.\"\n  ],\n  \"de_ai_title\": \"SUPER BUGS Act 2026: Globale Strategie gegen Pandemien und resistente Keime\",\n  \"de_summary\": \"Dieses Gesetz verpflichtet die US-Regierung zur Entwicklung einer internationalen Strategie für medizinische Produkte gegen Pandemien. Ziel ist es, Infektionskrankheiten und antibiotikaresistente Erreger weltweit zu bekämpfen, bevor sie die USA erreichen.\",\n  \"de_key_points\": [\n    \"Entwicklung eines Plans zur internationalen Zusammenarbeit bei Impfstoffen und Medikamenten.\",\n    \"Fokus auf die Bekämpfung von 'Supererregern', die gegen Antibiotika resistent sind.\",\n    \"Stärkung der Gesundheitssysteme von Partnerländern zur frühzeitigen Erkennung von Ausbrüchen.\",\n    \"Einbindung des Privatsektors zur Beschleunigung medizinischer Innovationen.\"\n  ],\n  \"fr_ai_title\": \"Loi SUPER BUGS 2026 : Stratégie mondiale contre les pandémies et bactéries résistantes\",\n  \"fr_summary\": \"Cette loi impose la création d'une stratégie internationale pour accélérer le développement de médicaments et vaccins contre les pandémies. L'objectif est de stopper les maladies infectieuses à l'étranger avant qu'elles ne menacent la sécurité sanitaire des citoyens.\",\n  \"fr_key_points\": [\n    \"Élaboration d'un plan de coopération internationale pour les produits médicaux d'urgence.\",\n    \"Priorité à la lutte contre les bactéries résistantes aux antibiotiques.\",\n    \"Renforcement des capacités de détection des maladies dans les pays partenaires.\",\n    \"Collaboration avec le secteur privé pour favoriser l'innovation médicale.\"\n  ],\n  \"es_ai_title\": \"Ley SUPER BUGS 2026: Estrategia global contra pandemias y bacterias resistentes\",\n  \"es_summary\": \"Esta ley exige crear una estrategia internacional para facilitar el desarrollo de vacunas y tratamientos contra futuras pandemias. Busca detener las amenazas de enfermedades infecciosas fuera de las fronteras para proteger la salud y seguridad nacional.\",\n  \"es_key_points\": [\n    \"Creación de un plan para obtener apoyo internacional en el desarrollo de productos médicos.\",\n    \"Enfoque en combatir patógenos resistentes a los antibióticos con potencial pandémico.\",\n    \"Mejora de la capacidad de otros países para detectar y contener brotes rápidamente.\",\n    \"Fomento de alianzas con empresas privadas para acelerar soluciones médicas.\"\n  ],\n  \"it_ai_title\": \"Legge SUPER BUGS 2026: Strategia globale contro pandemie e batteri resistenti\",\n  \"it_summary\": \"Questa legge richiede lo sviluppo di una strategia internazionale per accelerare la creazione di farmaci e vaccini contro le pandemie. L'obiettivo è fermare le malattie infettive prima che raggiungano i confini nazionali, proteggendo la salute pubblica.\",\n  \"it_key_points\": [\n    \"Definizione di un piano di cooperazione globale per lo sviluppo di contromisure mediche.\",\n    \"Focus sulla lotta ai batteri resistenti agli antibiotici che minacciano la sicurezza.\",\n    \"Rafforzamento delle capacità dei paesi partner nel rilevare e contenere i focolai.\",\n    \"Coinvolgimento del settore privato per velocizzare l'innovazione tecnologica in medicina.\"\n  ],\n  \"nl_ai_title\": \"SUPER BUGS Act 2026: Wereldwijde strategie tegen pandemieën en resistente bacteriën\",\n  \"nl_summary\": \"Deze wet verplicht de overheid om een internationale strategie te ontwikkelen voor de productie van vaccins en medicijnen tegen pandemieën. Het doel is om infectieziekten wereldwijd aan te pakken voordat ze een bedreiging vormen voor de nationale veiligheid.\",\n  \"nl_key_points\": [\n    \"Opstellen van een plan voor internationale samenwerking bij medische productontwikkeling.\",\n    \"Focus op de bestrijding van antibioticaresistente bacteriën met pandemisch potentieel.\",\n    \"Versterken van de volksgezondheid in partnerlanden om uitbraken sneller te stoppen.\",\n    \"Samenwerking met de private sector voor snellere medische innovaties.\"\n  ],\n  \"pt_ai_title\": \"Lei SUPER BUGS 2026: Estratégia global contra pandemias e bactérias resistentes\",\n  \"pt_summary\": \"Esta lei exige a criação de uma estratégia internacional para acelerar o desenvolvimento de vacinas e tratamentos contra pandemias. O objetivo é conter doenças infeciosas no estrangeiro antes que estas cheguem ao país e afetem a segurança dos cidadãos.\",\n  \"pt_key_points\": [\n    \"Criação de um plano de cooperação global para o desenvolvimento de produtos médicos.\",\n    \"Foco no combate a bactérias resistentes a antibióticos com potencial pandémico.\",\n    \"Reforço da capacidade dos países parceiros para detetar e conter surtos precocemente.\",\n    \"Parcerias com o setor privado para acelerar a inovação em saúde pública.\"\n  ],\n  \"category\": [\n    \"Health\",\n    \"Security\"\n  ]\n}"
    }
  ]
}